Vertex Pharmaceuticals exec Altshuler sells 3,231 common shares
In a regulatory filing, Vertex Pharmaceuticals (VRTX) chief scientific officer David Altshuler disclosed the sale of 3,231 common shares of the ...
Yahoo Finance1d
Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $502.92, signifying a +1.51% move from its prior day's close. We recently published a list of the 11 Best Pharma Stocks to Buy ...
pharmaphorum3d
Vertex buys diabetes cell therapy rival ViaCyte for $320m
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Yahoo Finance1d
Vertex Pharmaceuticals Incorporated (VRTX)
After hours: March 17 at 7:28:04 PM EDT Loading Chart for VRTX ...
Investing Snacks5d
Vertex EVP Sells $1.62M in Stock Amid Market Highs
Vertex Pharmaceuticals EVP Ourania Tatsis sold 3,242 shares worth $1.62 million under a pre-arranged plan. The sale, executed on March 10, 2025, priced each share at $499.99, with Tatsis still holding ...